Health Economics Policy and Law

Papers
(The median citation count of Health Economics Policy and Law is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Genomics and insurance in the United Kingdom: increasing complexity and emerging challenges116
Fellow travellers in transformative times: a reflection on 21 years membership of the European Health Policy Group48
HEP volume 17 issue 4 Cover and Back matter19
Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis17
Pricing strategies, executive committee power and negotiation leverage in New Zealand's containment of public spending on pharmaceuticals15
Institutional boundaries and the challenges of aligning science advice and policy dynamics: the UK and Canada in the time of COVID-1912
New governance of the digital health agency: a way out of the joint decision trap to implement electronic health records in Germany?12
From speculative to real: community attitudes towards government COVID-19 vaccine mandates in Western Australia from May 2021 to April 202212
Politics in all policies: how healthcare is shaped by political (in)action9
Saving children's lives through interventions: a quasi-experimental analysis of GAVI9
The federal government and Canada's COVID-19 responses: from ‘we're ready, we're prepared’ to ‘fires are burning’9
Managed competition in Colombia: convergence of public and private insurance and delivery6
Out with the old…6
HEP volume 17 issue 2 Cover and Front matter6
Preconditions for efficiency and affordability in mixed health systems: are they fulfilled in the Australian public–private mix?5
HEP volume 16 issue 4 Cover and Front matter5
A review of heath economic evaluation practice in the Netherlands: are we moving forward?5
An examination of health care efficiency in Canada: a two-stage semi-parametric approach4
Fair processes for financing universal health coverage?4
Healthcare reform in the Netherlands: after 15 years of regulated competition3
Australia's Response to COVID-193
Value-based evidence across health care sectors: a push for transparent real-world studies, data, and evidence dissemination3
The state of American health coverage: the 2022 elections and the Affordable Care Act3
Exploring differences between public and private providers in primary care: findings from a large Swedish region2
Does Medicaid expansion influence county health spending? A case of New York counties2
The roads to managed competition for mixed public–private health systems: a conceptual framework2
Navigating conflicting expectations in addressing healthcare scarcity: a q-methodology study on the Dutch National Health Care Institute2
Neighborhood inequalities and the decline of infant mortality in São Paulo2
HEP volume 17 issue 1 Cover and Front matter2
Medical marijuana laws and mental health in the United States2
Privatising, liberalising and dividing a welfare state without affecting universality? Debunking the myths surrounding the rapid rise of private health insurance in Sweden2
Financial risk protection in private health insurance: empirical evidence on catastrophic and impoverishing spending from Germany's dual insurance system2
Political determinants of health: (re) examining the role of governance in reducing maternal mortality2
Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework2
Early child health in Africa: do ICT and democracy matter?1
Past experiences with surprise medical bills drive issue knowledge, concern and attitudes toward federal policy intervention1
Need, demand, supply in health care: working definitions, and their implications for defining access1
Response to critics of Open and Inclusive: Fair Processes for Financing Universal Health Coverage1
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era1
Health misinformation and freedom of expression: considerations for policymakers1
HEP volume 16 issue 3 Cover and Front matter1
‘Nurses are seen as general cargo, not the smart TVs you ship carefully’: the politics of nurse staffing in England, Spain, Sweden, and the Netherlands1
… and in with the new1
Why procedural fairness is essential to financing universal health coverage1
How to fairly allocate scarce medical resources? Controversial preferences of healthcare professionals with different personal characteristics1
Integrated care in a Beveridge system: experiences from England and Denmark1
Private equity involvement in primary care: the case of Ireland1
Do consumers perceive and trust health insurers within a system of managed competition as prudent buyers of care?1
Successfully changing the mode of regulation in clinical priority setting: how organisational factors contributed to establishing the Norwegian priority guidelines for specialist health care services1
Success and failure in establishing national physician databases: a comparison between Canada and Israel0
Managed competition in the United States: How well is it promoting equity and efficiency?0
Virtual reality evidence on the impact of physicians' open versus defensive communication on patients0
Health care reform and financial crisis in the Netherlands: consequences for the financial arena of health care organizations0
HEP volume 17 issue 2 Cover and Back matter0
Implications of the fair processes for financing UHC report for development assistance: reflections and an application of the decision-making principles to PEPFAR0
HEP volume 16 issue 3 Cover and Back matter0
HEP volume 17 issue 3 Cover and Front matter0
Soft law and individual responsibility: a review of the Swedish policy response to COVID-190
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment0
Learning lessons from the COVID-19 pandemic0
Value assessment and decision-making: how to move health systems forward?0
Publicly funded health insurance schemes and demand for health services: evidence from an Indian state using a matching estimator approach0
Strengthening primary health care in China: governance and policy challenges0
Pandemic preparedness and response: a new mechanism for expanding access to essential countermeasures0
HEP volume 17 issue 1 Cover and Back matter0
Any lessons to learn? Pathways and impasses towards health system resilience in post-pandemic times0
How should medicines reimbursement work? The views of Spanish experts0
The effects of a sugar-sweetened beverage tax: moving beyond dental health outcomes and service utilisation0
Is the emergency department used as a substitute or a complement to primary care in Medicaid?0
The impact of surprise billing laws on hospital-based physician prices and network participation0
Understanding household healthcare expenditure can promote health policy reform0
Roadmaps to managed competition: to what extent does South Africa meet the preconditions for equity and efficiency?0
Health insurance and fertility among low-income, childless, single women: evidence from the ACA Medicaid expansions0
If you were a policymaker, which treatment would you disinvest? A participatory value evaluation on public preferences for active disinvestment of health care interventions in the Netherlands0
Including carer health-related quality of life in NICE health technology assessments in the United Kingdom0
Précis of Open and Inclusive: Fair Processes for Financing Universal Health Coverage0
HEP volume 17 issue 3 Cover and Back matter0
Emergency care reconfiguration in the Netherlands: conflicting interests and trade-offs from a multidisciplinary perspective0
Belgium's response to the COVID-19 pandemic0
Navigating health systems in times of inequality and uncertainty… And how we go from here0
The prevalence and consequences of support for off-label Ozempic prescriptions0
What's the ideal World Health Organization (WHO)?0
Impact on the NHS and health of the UK's trade and cooperation relationship with the EU, and beyond0
Strengthening health system governance in Germany: looking back, planning ahead0
Ten years of German benefit assessment: price analysis for drugs with unproven additional benefit0
Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes0
Why did England change its law on deceased organ donation in 2019? The dynamic interplay between evidence and values0
The normative grounds for NICE decision-making: a narrative cross-disciplinary review of empirical studies0
Globalisation and mental health: is globalisation good or bad for mental health? Testing for quadratic effects0
HEP volume 17 issue 4 Cover and Front matter0
Balancing between competition and regulation in healthcare markets0
HEP volume 16 issue 4 Cover and Back matter0
Ireland's takeover of private hospitals during the COVID-19 pandemic0
Just a question of time? Explaining non-take-up of a public health insurance program designed for undocumented immigrants living in France0
The forgotten dimension of integrated care: barriers to implementing integrated clinical care in English NHS hospitals0
A systematic literature review of real-world evidence (RWE) on post-market assessment of medical devices0
Consolidating political leadership in healthcare: a mediating institution for priority-setting as a political strategy in a local health system0
Improving access to healthcare in Ireland: an implementation failure0
What is a ‘National’ ‘Health’ ‘Service’? A keyword analysis of policy documents leading to the formation of the UK NHS0
Just informal patient payments are not enough, ‘personal connections’ and knowledge of the ‘rules’ are also required: a logistic regression analysis of informal practices in health care in Ukraine0
Special issue: On the roof top of health policy change: overlooking 21 years of the European Health Policy Group0
Public health by organizational fix?0
Effects of public long-term care insurance on the medical service use by older people in South Korea0
Structuring complexity? A systemic perspective on the implementation of a disease management programme for type II diabetes care in Denmark0
Changing roles of health insurers in France, Germany, and the Netherlands: any lessons to learn from Bismarckian systems?0
US public opinion about interior border checkpoints and health care access for undocumented immigrants0
The inefficient effects of non-clinical factors on health care costs0
Understanding public procurement within the health sector: a priority in a post-COVID-19 world0
Managed competition in Aotearoa New Zealand: past experiences and future prospects0
Pricing of hospital services: evidence from a thematic review0
Exploring the uptake of economic evaluation in Spanish reports positioning medicines for public reimbursement0
Procedural fairness to recalibrate the power imbalance in health decision-making: comment on the report: ‘Open and inclusive: Fair processes for financing universal health coverage’0
Enhancing procedural fairness: a critique of the open and inclusive approach to health financing decisions0
Learning lessons about lesson-learning: Covid complexity0
How reforms hamper priority-setting in health care: an interview study with local decision-makers in London0
Spillover effects of financial incentives for providers onto non-targeted patients: daycase surgery in English hospitals0
Coping with COVID-19: the role of hospital care structures and capacity expansion in five countries0
0.10285806655884